Circulating microRNAs: promising breast cancer Biomarkers.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.Cell communication and signaling : CCS · 2023
   Review
2. Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.Nature communications · 2022
   Article
3. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
   Article
4. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.Asian Pacific journal of cancer prevention : APJCP · 2019
   Article
5. PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma.Oncotarget · 2017
   Article
6. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.BMC cancer · 2017
   Article
7. Dietary RNAs: New Stories Regarding Oral Delivery.Nutrients · 2015
   Review
8. Regulation of cancer metastasis by cell-free miRNAs.Biochimica et biophysica acta · 2015
   Review
9. Detection of an Abundant Plant-Based Small RNA in Healthy Consumers.PloS one · 2015
   Article
10. Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.PloS one · 2014
    Article
11. Pancreatic cancer diagnosis by free and exosomal miRNA.World journal of gastrointestinal pathophysiology · 2013
    Review
12. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities.Current pathobiology reports · 2013
    Article
13. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.Journal of cancer research and clinical oncology · 2013
    Article
14. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer.BMC medical genetics · 2012
    Article
15. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours.Cellular oncology (Dordrecht, Netherlands) · 2012
    Article
16. MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis.Breast cancer research : BCR · 2012
    Article
17. Serum microRNA-155 as a potential biomarker to track disease in breast cancer.PloS one · 2012
    Article
18. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer.PloS one · 2012
    Article
19. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.PloS one · 2012
    Article

Corrections and comments

• Comment on
  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.2010

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as